take phenylpropanolamine off the market

December 2000

The FDA's decision to take phenylpropanolamine off the market is causing quite a stir.

Patients are asking for alternates now that PPA is associated with a risk of hemorrhagic stroke...especially in young women.

There are plenty of allergy and cold meds that use different decongestants than phenylpropanolamine (PPA).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

fibromyalgia
take phenylpropanolamine off the market
Diabetes more focus on lowering POSTPRANDIAL glucose
Cardiology high potassium foods may reduce the risk of high blood pressure and stroke
Cardiology guidelines for potassium replacement
Cardiology new low-molecular-weight heparin called Innohep
Gastroenterology Colazal (KOL-a-zal), a new drug for ulcerative colitis
Infectious Diseases Relenza and Tamiflu to PREVENT flu
Infectious Diseases shortage of ADULT tetanus-diphtheria vaccine
DHEA (dehydroepiandrosterone) is useful for treating lupus
Women's Health using testosterone for women
Women's Health Menopause Educator Certificate
You'll see two new meds for HIV
Multiple Sclerosis multiple sclerosis patients using Novantrone
Dispensing Centralized facilities and unit-of-use packaging